| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/28/1994 | US5324737 Analgesics, antirheumatic and antiinflammatory agents, glaucoma |
| 06/28/1994 | US5324733 Selective ligands at sigma recognition sites |
| 06/28/1994 | US5324724 Azabicyclic compounds; Alzheimer's disease treatment |
| 06/28/1994 | CA1330440C Benzimidazole derivatives |
| 06/26/1994 | CA2111931A1 .alpha.-aminoketone derivatives |
| 06/25/1994 | CA2112160A1 Compositions of l-dopa esters |
| 06/23/1994 | WO1994013678A1 Spirofuranone derivatives and their use in the treatment of neurodegenerative disorders |
| 06/23/1994 | WO1994013677A1 Pyrazolopyrimidines as crf antagonists |
| 06/23/1994 | WO1994013676A1 Pyrrolopyrimidines as crf antagonists |
| 06/23/1994 | WO1994013673A1 New triazolopyrimidones, their preparation and their use |
| 06/23/1994 | WO1994013672A1 New triazoloquinazolines, their production and their use |
| 06/23/1994 | WO1994013663A1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists |
| 06/23/1994 | WO1994013661A1 Substituted pyrazoles as crf antagonists |
| 06/23/1994 | WO1994013659A1 Fused benzo compounds |
| 06/23/1994 | WO1994013658A2 Benzocycloheptenes, benzoxepines and benzothiepines |
| 06/23/1994 | WO1994013657A1 Pharmaceutical composition containing bicyclic type compounds |
| 06/23/1994 | WO1994013656A1 Bicyclic compounds with pharmaceutical activity |
| 06/23/1994 | WO1994013651A1 Benzazepinone derivatives |
| 06/23/1994 | WO1994013644A1 Amino-substituted pyrazoles having crf antagonistic activity |
| 06/23/1994 | WO1994013643A1 Pyrazoles and pyrazolopyrimidines having crf antagonist activity |
| 06/23/1994 | WO1994013639A1 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperidines as tachykinin receptor antagonists |
| 06/23/1994 | WO1994013620A1 Aminomethylindans, -benzofuranes and -benzothiophenes |
| 06/23/1994 | WO1994013319A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
| 06/23/1994 | WO1994013308A1 A burn remedial composition using natural materials and its production method |
| 06/23/1994 | WO1994013303A1 Administration of oligonucleotides antisense to dopamine receptor mrna for diagnosis and treatment of neurological pathologies |
| 06/23/1994 | WO1994013298A1 Application of carbamazepine and oxcarbazepine in the treatment of neurological lesions related to traumatic injuries |
| 06/23/1994 | WO1994013297A1 Potassium channel activators and use thereof in therapy |
| 06/23/1994 | WO1994013296A1 Application of lamotrigine in the treatment of neurological lesions related to traumatic injuries |
| 06/23/1994 | WO1994013294A1 Triazoloquinazolines for the treatment of diseases of the central nervous system |
| 06/23/1994 | WO1994013292A1 Potassium channel activators for use in therapy |
| 06/23/1994 | WO1994013291A1 Use of aryloxyalkyl substituted cyclic amines as calcium channel antagonists and new phenyloxyalkyl piperidin derivatives |
| 06/23/1994 | WO1994013288A1 Application of riluzole in the treatment of neurological lesions related to traumatic injuries |
| 06/23/1994 | WO1994013287A1 Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an anti-depressant drug |
| 06/23/1994 | WO1994013285A1 Use of idazoxan and derivatives thereof in preparing a drug for treating parkinson's disease and its development |
| 06/23/1994 | WO1994013283A1 Antipyretic and analgesic methods and compositions containing optically pure r-ketorolac |
| 06/23/1994 | WO1994013281A1 Anti-inflammatory and analgesic gel preparation |
| 06/23/1994 | WO1994013280A1 Sprayable analgesic composition and method of use |
| 06/23/1994 | WO1994013279A1 Effervescent pharmaceutical composition containing ibuprofen and method for preparing same |
| 06/23/1994 | WO1994013278A1 Methods for treatment with dimercaptosuccinic acid (dmsa) |
| 06/23/1994 | CA2151927A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
| 06/23/1994 | CA2151747A1 Methods for treatment with dimercaptosuccinic acid (dsma) |
| 06/23/1994 | CA2151603A1 Application of anticonvulsant in the treatment of neurological lesions associated with traumas |
| 06/23/1994 | CA2151601A1 Application of lamotrigin in the treatment of neurological lesions associated with traumas |
| 06/23/1994 | CA2151585A1 Administration of oligonucleotides antisense to dopamine receptor mrna for diagnosis and treatment of neurological pathologies |
| 06/23/1994 | CA2151515A1 Bicyclic compounds with pharmaceutical activity |
| 06/23/1994 | CA2151384A1 Benzazepinone derivatives |
| 06/23/1994 | CA2151378A1 1,4-disubstituted 4-fused phenyl piperidines and piperazines as high-affinity ligands for 5h-t1a receptor |
| 06/23/1994 | CA2151243A1 Novel triazolopyrimidones, their preparation and use |
| 06/23/1994 | CA2151242A1 Novel triazoloquinazolines, their preparation and use |
| 06/23/1994 | CA2151241A1 Triazoloquinazolines for the treatment of central nervous disorders |
| 06/23/1994 | CA2151039A1 Idazoxan and derivatives thereof used for preparing a drug intended for the treatment of parkinsons's desease |
| 06/23/1994 | CA2150951A1 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperidines as tachykinin receptor antagonists |
| 06/23/1994 | CA2150947A1 Spirofuranone derivatives and their use in the treatment of neurodegenerative disorders |
| 06/23/1994 | CA2129642A1 Benzocycloheptenes, benzoxepines and benzothiepines |
| 06/22/1994 | EP0602112A1 High content ibuprofen agglomerates and process to prepare them |
| 06/22/1994 | CN1088201A Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids |
| 06/21/1994 | US5322944 Process for the synthesis of enantiomers of 3-aminochroman compounds |
| 06/21/1994 | US5322849 Benzoxazalinonyl and benzothiazolinonyl ethyl isonicotine amides and piperidonamides |
| 06/21/1994 | US5322848 N-acyl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals |
| 06/21/1994 | US5322846 Useful in treatment of cardiovascular diseases associated with hyperactivity of the sympathetic nervous system |
| 06/21/1994 | US5322843 Treating sleep disorders |
| 06/21/1994 | CA1330341C Imidazole derivatives ii |
| 06/15/1994 | EP0601508A2 Liquid-suspension controlled-release pharmaceutical composition |
| 06/15/1994 | EP0600974A1 Preparation of medicaments containing the peptidoglycan monomer or its derivatives |
| 06/15/1994 | EP0600955A1 5-ht4 receptor antagonists |
| 06/15/1994 | EP0600875A1 Purification of recombinant apolipoprotein e from bacteria |
| 06/15/1994 | EP0396734B1 Pharmaceutical compositions for neuro protection containing arylcyclohexylamines |
| 06/15/1994 | CN1087902A Morpholine and thiomorpholine tachykinin receptor antagonists |
| 06/15/1994 | CN1087901A Novel pyridyl- and pyrimidylpiperazine derivatives |
| 06/15/1994 | CN1025031C 2-oxo-3,8-diaza-spiro|4,5¨ decane derivatives, |
| 06/15/1994 | CN1025027C Prepn. of thiophen-2-oxatyl amidate |
| 06/14/1994 | US5321039 Method of inducing a histamine agonist action on H2 receptors |
| 06/14/1994 | US5321027 Analgesic |
| 06/14/1994 | US5321026 Phenothiazine derivatives, their preparation and pharmaceutical compositions containing them |
| 06/14/1994 | US5321023 Pyridoindolobenzodiazepines and derivatives as antipsychotics |
| 06/14/1994 | US5321012 Using nontoxic material such as dextromethorphan, trifluoro-perazine, dextrorphan |
| 06/09/1994 | WO1994012539A1 Multifunctional neurotrophic factors |
| 06/09/1994 | WO1994012532A1 New oligopeptides with affinity to opioid receptors |
| 06/09/1994 | WO1994012498A1 METHOD OF PREPARING β-CARBOLINES |
| 06/09/1994 | WO1994012494A1 Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists |
| 06/09/1994 | WO1994012466A1 Fatty acid derivatives and pharmaceutical compositions containing them |
| 06/09/1994 | WO1994012463A1 Nitric esters having a pharmacological activity and process for their preparation |
| 06/09/1994 | WO1994012201A1 Use of fibroblast growth factors as neuroprotective and neuromodulatory agents |
| 06/09/1994 | WO1994012200A1 Dry mix formulation for bisphosphonic acids |
| 06/09/1994 | WO1994012176A1 Use of phenserine to treat cognitive disorders |
| 06/09/1994 | WO1994012153A1 A pharmaceutical formulation |
| 06/09/1994 | WO1993012093A1 Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists |
| 06/09/1994 | CA2527566A1 Use of phenserine to treat cognitive disorders |
| 06/09/1994 | CA2149918A1 Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
| 06/09/1994 | CA2149899A1 New oligopeptides with affinity to opioid receptors |
| 06/09/1994 | CA2149862A1 Multifunctional neurotrophic factors |
| 06/09/1994 | CA2149303A1 Method of preparing .beta.-carbolines |
| 06/09/1994 | CA2127537A1 Use of fibroblast growth factors as neuroprotective and neuromodulatory agents |
| 06/08/1994 | EP0600717A1 Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis |
| 06/08/1994 | EP0600582A1 Treatment for muscular dystrophy |
| 06/08/1994 | EP0600395A1 Antinflammatory and analgesic diclofenac gel preparation |
| 06/08/1994 | EP0600278A2 Glutamate receptor protein and gene coding the same |
| 06/08/1994 | EP0506853B1 The use of gaba-b selective agonists as anti-tussive agents |
| 06/08/1994 | EP0486586B1 Kynurenic acid derivatives, their preparation and pharmaceutical compositions containing them |
| 06/08/1994 | CN1087629A New indol derivatives |